Wordt geladen...

HOUT-09. USING THE ASCO AND ESMO FRAMEWORKS TO ASSESS THE CLINICAL VALUE OF TUMOR TREATING FIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

BACKGROUND: The effectivity and safety of TTFields in newly diagnosed GBM was recently demonstrated by the final analysis of the large, randomized controlled EF-14 Trial. To capture the clinical value of new cancer treatments, the American Society of Clinical Oncology (ASCO) and the European Society...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Kelly, Justin, Proescholdt, Christina, Bähr, Oliver
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2018
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217041/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.477
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!